Eurosirel is a Private Equity–backed European medical devices and consumer health platform, delivering end-to-end development and manufacturing of Made in Italy solutions for leading pharmaceutical and healthcare brands.

With 50 years of industrial heritage, Eurosirel operates as a market leader in private label medical devices in Europe, producing 1.5 billion units per year and serving 1 in 2 European families. We support more than 800 active customers, across 60 countries, with a portfolio spanning wound care and advanced dressings, pain management devices, transdermal patches, diagnostics & prevention, and beauty-med solutions.

Innovation and quality are core to our platform. We invest ~10% of annual revenue in R&D, own advanced and proprietary technologies, and operate under 60+ international certifications (including ISO 13485 and ISO 22716), ensuring compliance and scalability in highly regulated environments.

Backed by Private Equity, Eurosirel is executing a clear growth and value creation strategy:

International expansion, with active entry into the US and further global markets

Portfolio expansion in high-value care and beauty categories

Manufacturing and operational excellence to support scale

Strategic partnerships and M&A to accelerate platform growth

With a strong European manufacturing footprint, a customer-centric culture, and a proven ability to scale, Eurosirel is a trusted partner for US and international companies seeking high-quality, compliant, and innovation-driven medical devices and consumer health solutions.

EUROSIREL SPA

Org chart

Teams

Offices